Lucky mice. Time will tell if it matters for humans. Here’s the study. And the Newsweek write up on it.
Another great article by the WAPO’s Ariana Eunjug Cha. Here’s a small excerpt from the piece: “As a tidal wave of new health-related gadgets, apps and tests hits the market, government agencies like the FDA, Federal Trade Commission and others
Note that the results are for mice only (so far). Human trials are coming soon. Here’s the University press release. And the news story. “Researchers have discovered that an injection of a protein called IL-33 can reverse Alzheimer’s-like symptoms and
From the Washington Post. “Scientists reported Tuesday on two new studies showing that the medications, which marshal the body’s own immune defenses, are now proving effective against recurrent, difficult-to-treat head and neck cancer and an extremely lethal skin cancer called
Here’s some interesting news from The Scripps Research Institute (TSRI) and the Mayo Clinic. Researchers found that a combination of two drugs — cancer drug dasatinib and quercetin — “dramatically slows the aging process (in animal models)—alleviating symptoms of frailty,
Looking forward to seeing how this rolls out next year! Read the story here and here.
It’s not a cure, but it’s a start towards one. From the NYT: “Five years ago, a college freshman named Ian Burkhart dived into a wave at a beach off the Outer Banks in North Carolina and, in a freakish
A new study shows that, for a small number of lucky individuals, it is possible to have a faulty gene that causes severe disease and not get that disease (think cystic fibrosis, etc). The problem though is that researchers don’t
From the Telegraph: “Researchers from Orlando Health in Florida detected a biomarker released by the brain during injury. They found that the biomarker can stay in the bloodstream for up to a week – which means patients who suffer delayed
Here it is — the $1000 whole genome. Veritas Genetics is co-founded by Harvard Medical School professor and genetics pioneer Dr. George Church. The company first broke the $1,000 genome barrier in 2015 when it made whole genome sequencing available